Citation Impact

Citing Papers

Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Akt2 Phosphorylates Ezrin to Trigger NHE3 Translocation and Activation
2004
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
A Novel Approach to Decoy Set Generation: Designing a Physical Energy Function Having Local Minima with Native Structure Characteristics
2003 StandoutNobel
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
In situ generation of Fmoc‐amino acid chlorides using bis‐(trichloromethyl)carbonate and its utilization for difficult couplings in solid‐phase peptide synthesis
1999
Expression and purification of active PKB kinase from Escherichia coli
2005
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Amide bond formation: beyond the myth of coupling reagents
2008 Standout
Identification of Small-Molecule Inhibitors of Protein Kinase B (PKB/AKT) in an AlphaScreen™ High-Throughput Screen
2006
Marine natural products
1990 Standout
A review of drug release mechanisms from nanocarrier systems
2017
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Binding a heparin derived disaccharide to defensin inspired peptides: insights to antimicrobial inhibition from gas-phase measurements
2010 StandoutNobel
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
2014 Standout
Site-specific N-terminal labeling of proteins using sortase-mediated reactions
2013
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
MAP kinase signalling pathways in cancer
2007 Standout
Cancer genes and the pathways they control
2004 Standout
Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab
2013
Empirical modifications to the Amber/OPLS potential for predicting the solution conformations of cyclic peptides by vacuum calculations
1998
Upstream and downstream of mTOR
2004 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
2014
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Intestinal mucosal barrier function in health and disease
2009 Standout
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Molecular requirements for epithelial–mesenchymal transition during tumor progression
2005 Standout
Conformationally Homogeneous Heterocyclic Pseudotetrapeptides as Three‐Dimensional Scaffolds for Rational Drug Design: Receptor‐Selective Somatostatin Analogues
2009
Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials–State of the Art
2018
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Defining the Role of mTOR in Cancer
2007 Standout
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
2007 Standout
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Multifunctional polymeric micelles for delivery of drugs and siRNA
2014
The synthesis of bioactive indolocarbazoles related to K-252a
2005
The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt
2004
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions
2004 Standout
Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine–Cysteine Bond Formation
2020 StandoutNobel
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
2015
Comprehensive Survey of Combinatorial Library Synthesis:  2002
2003
Fluorescent chemosensors: the past, present and future
2017 Standout
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Glycosidase activated release of fluorescent 1,8-naphthalimide probes for tumor cell imaging from glycosylated ‘pro-probes’
2016
Therapeutic potential of phosphoinositide 3-kinase inhibitors
2004
In Vivo Analysis of Biodegradable Liposome Gold Nanoparticles as Efficient Agents for Photothermal Therapy of Cancer
2015
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
A General NMR Method for Rapid, Efficient, and Reliable Biochemical Screening
2003
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products
2012
Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway
2006
Analysis of nanoparticle delivery to tumours
2016 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Redox Signaling by Reactive Electrophiles and Oxidants
2018
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003

Works of Gary Gellerman being referenced

Photosensitizer–Antibiotic Conjugates: A Novel Class of Antibacterial Molecules
2009
Targeted drug delivery for cancer therapy: the other side of antibodies
2012
Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide
2012
Toward a PKB Inhibitor:  Modification of a Selective PKA Inhibitor by Rational Design
2002
Facile Synthesis of Orthogonally Protected Optically Pure Keto- and Diketopiperazine Building Blocks for Combinatorial Chemistry
2008
A Backbone-Cyclic, Receptor 5-Selective Somatostatin Analogue:  Synthesis, Bioactivity, and Nuclear Magnetic Resonance Conformational Analysis
1998
Biolabile peptidyl delivery systems toward sequential drug release
2015
Recent Developments in the Synthesis and Applications of Anticancer Amonafide Derivatives. A Mini Review
2015
Rankless by CCL
2026